Overview

Long-term, Open-label Follow-up Treatment of Patients With A-fib Who Have Been Previously Treated With BIBR 1048

Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To determine the long term safety and efficacy of BIBR 1048 in patients with chronic atrial fibrilla tion, with or without concomitant chronic treatment with acetylsalicylic acid (ASA).
Phase:
Phase 2
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Dabigatran